8-K
Earth Science Tech, Inc. (ETST)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 9, 2023
Commission
File No. 000-55000
EARTH
SCIENCE TECH, INC.
(Exact name of registrant as specified in its charter)
| florida | 80-0961484 |
|---|---|
| (State or other jurisdiction<br> of | (I.R.S. Employer |
| incorporation or organization) | Identification No.) |
8950SW 74 th CT
Suite101
Miami,FL 33156, USA
(Address of principal executive offices, zip code)
(305)724-5684
(Registrant’s telephone number, including area code)
10650NW 29th Terrace
Doral,FL 33172, USA
(Former name, former address and former fiscal year, if changed since last report)
Securities
registered pursuant to Section 12(g) of the Act:
| Title of Each Class | Trading Symbol | Name of each exchange on which registered |
|---|---|---|
| Common Stock $0.001 par<br> value | ETST | Over the Counter Bulletin<br> Board |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communication pursuant<br> to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant<br> to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications<br> pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications<br> pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item7.01 Regulation FD Disclosure
On August 9, 2023, Earth Science Tech, Inc., a Florida corporation (the “Company”) issued a press release (the “Release”) announcing the launch of DocProtocol.com.
The information included in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth under this Item 7.01 shall not be deemed an admission as to the materiality of any information in this Current Report on Form 8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.
Item9.01. Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description |
|---|---|
| 99.1 | Press release issued by the registrant on August 9, 2023. |
| 104 | Cover Page Interactive<br> Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| **** | EARTH SCIENCE TECH, INC. | |
|---|---|---|
| Dated: August 9, 2023 | By: | /s/ Giorgio R. Saumat |
| Giorgio R. Saumat | ||
| **** | Its: | CEO and Chairman of the Board |
Exhibit99.1
EarthScience Tech, Inc. Launches DocProtocol.com
Miami, FL, August 9, 2023, Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a holding entity currently focused on the health and wellness industry, today announces the launch of DocProtocol.com (“DocProtocol”).
As mentioned in the July 28, 2023, announced record fiscal Q1 2023 financial results, the Company created DocProtocol in May 2023. DocProtocol is operated by ETST’s subsidiary Peaks Curative (“Peaks”), and offers patient specific protocols to doctors and wellness centers for their patients. The protocols are developed by highly respected functional medicine professionals, and the company anticipates this asset will generate sales for two of its subsidiaries; Peaks Curative and RxCompoundStore..
DocProtocol makes it easy for Doctors, Healthcare Professionals, and Health & Wellness clinics to enter patient specific data (Age, Sex, Blood Panel, Etc.) and receive a protocol to treat the goals of the specific patient. The initial set of protocol offerings include: Weight Loss, Testosterone Therapy, Active Virus Therapy, Immune Booster Therapy, Long Acting Virus Therapy, Erectile Dysfunction, PMS Therapy, Body Sculpting and more. Over time, these protocols will be updated to adhere to changes in the medical landscape and new protocols will be added to address patient goals. Most of the protocols generated by DocProtocol require patient specific medications that can only be fulfilled by a compounding pharmacy.
Peaks Curative plans to monetize this asset for the benefit of ETST by charging a monthly fee to medical professionals for the use of DocProtocol as well as driving prescriptions to RxCompoundStore.
ETST’s CEO and Chairman of the Board, Giorgio R. Saumat comments, “Every asset we have acquired or launched in the last 10 months isgeared towards growing the overall revenue and cash flow of the company. As each asset has come online, revenues have increased. To date,we have been successful with every asset launch. This is validation of the growth strategy management has implemented.
Weexpect DocProtocol to increase revenue and cash flow for ETST in two ways. Initially it will be indirect by offering a tool to providersthat will require fulfillment by a compounding pharmacy of the patient’s choice. Then we expect providers to recognize the utilityof DocProtocol and be willing to pay a monthly fee for its use.
Thislaunch is consistent with our growth strategy and management’s commitment to executing that strategy.”
AboutEarth Science Tech, Inc.
Earth Science Tech, Inc. is a holding entity currently in compounding pharmaceuticals and telemedicine through its wholly owned subsidiaries RxCompoundStore.com, LLC., Peaks Curative, LLC. and Earth Science Foundation, Inc.
To learn more, please visit: www.EarthScienceTech.com
RxCompoundStore.com,LLC.
RxCompound is a complete compounding pharmacy. RxCompound is currently licensed to fulfill prescriptions in the states of Florida, New York, New Jersey, Delaware, Pennsylvania, Rhode Island, Nevada, Colorado, Arizona, Utah, Georgia, Wisconsin, Minnesota and Massachusetts. RxCompound is in the application process to obtain licenses in the remaining states in which it is not yet approved to ship prescriptions.
To learn more please visit: www.RxCompoundStore.com
AboutPeaks Curative, LLC.
Peaks is a telemedicine referral site focused on men’s health. Peaks’ orders are exclusively fulfilled by RxCompound. Patients who order Peaks via monthly subscription receive their refills automatically. Currently, Peaks is focused on Men’s health, and, more specifically, ED. The company intends to expand offerings to include over the counter (“OTC”) (non-prescription) products such as supplements and topicals. The OTC products will be custom manufactured or fulfilled through partnered companies under the Peaks brand and offered worldwide.
To learn more please visit: www.PeaksCurative.com
AboutEarth Science Foundation, Inc.
Earth Science Foundation Inc. is a favored entity of the Company, effectively being a non-profit organization that was incorporated on February 11, 2019, and is structured to accept grants and donations to help those in need of assistance in paying for prescriptions.
SAFEHARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, listing on the CSE, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
CompanyContact:
Nickolas S. Tabraue
Chief Compliance Officer
(786) 375-7281
Nick@earthsciencetech.com